While tirzepatide is designed to help control high blood sugar, it could potentially cause low blood sugar, as we mentioned earlier, leading to risks for both the mother and the baby
Nearly one-half billion dollars was spent on ads for these drugs in 2023 according to MediaRadar mostly on four drugs, three from Novo-Nordisk (namely Ozempic, Rybelsus and Wegovy) and Jardiance from Boehringer Ingelheim
SGLT2i are a class of drugs that we hypothesize may have a beneficial effect on these pathways 4 that are not well targeted by current treatment paradigms
Genetic testing results do not predict exact medication response but may help explain why tirzepatide timelines vary widely between individuals
Efficient delivery of GLP-1, which can aid in weight management and blood sugar control
This is why many in Kenner consider mounjaro telehealth options for seamless recommendations and prescriptions